Despite some industry resistance, the digital oil field concept is helping oil and gas companies drive offshore innovation and optimisation. Now that data analysis and wireless technologies are readily available to the industry, companies must ask themselves how they can make the most of the new information age…read more
Innovation tied to globalization & collaboration, by Kristin Brooks, Contract Pharma As drug developers face intensifying pressure from generic drug firms, patent expirations, and increased scrutiny from the FDA, efficiency is more important than ever. The pharma and biopharma industry no longer approaches drug development alone, and after years of reduced R&D spending, numbers are [...]
By Jason Ford A company in England is to design and develop essential controls that will help prevent one of the world’s most ambitious space missions from failing…read more
There is always something that stops me getting started, by Colin Smith Speaking with a number of corporate archivists and record managers I often hear that it’s easy to become stuck formulating the perfect archiving solution, and not really get started on implementing it…read more on page 2
By Andrew Cave. Obtaining the right talent and keeping it are two of the most significant issues facing mid-sized business…read more
The chief executive of Tessella, Alan Gaby, has five top tips for leading the buyout of an established company. Alan Gaby is chief executive of Tessella. He led an £18m buyout of the company that saw the founder sell down substantially his stake in the business…read more click here
To do useful data analytics in the oil and gas industry, you are better off defining the question you want answered and then gathering data to answer the question, rather than gathering data and then trying to work out what you can do with it, say Nicholas Clarke and Bas Hendriksen of Tessella… read more
Tessella have announced that it has won the tender process with the National Library of Australia for the Digital Library Infrastructure Redevelopment project…read more on page 40
In the not-so-distant future, the pharmaceutical industry will need to move away from serendipity and its “blockbuster” drug development approach to become a service-based business specializing in patient-specific therapeutics delivering desired outcomes at the desired price. Clinical trials, of necessity, will be re-engineered to reflect real-world circumstances and turn adaptive study programs into a competitive [...]
By Peter Mansell Pharmaceutical Product Development (PPD) is refining its design capabilities for adaptive clinical trials through a licence agreement with information technology and consulting services company Tessella and Berry Consultants, a statistical consulting group specialising in the Bayesian approach to medical statistics…read more
